Darifenacin
Cat. No.：YN321336
| 产品名称: | Darifenacin |
| CAS No.: | 133099-04-4 |
| Chemical Name: | 2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-pyrrolidin-3-yl)-2,2-diphenylacetamide; UK 88525; Vesigard; (3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-pyrrolidine; (S)-(-)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3- |
| Synonyms: | 达非那新; UK-88525 |
| 分子量: | 426.55 |
| 分子式: | C₂₈H₃₀N₂O₂ |
| SMILES: | O=C(N)C(C1=CC=CC=C1)([C@H]2CN(CCC3=CC=C(OCC4)C4=C3)CC2)C5=CC=CC=C5 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Darifenacin(UK88525)是M3毒蕈碱型受体拮抗剂，pKi为8.9。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Chapple, C., et al.: Eur. Urol. 54, 3, 543-562, (2008)
